Bio Insight Bio Reports

Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome

Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...

 May 28, 2024 | News

The Ascendant Biopharma Sector in APAC: Revealing Future Trends and Breakthrough Innovations

  The Asia-Pacific (APAC) region stands at the forefront of the biopharmaceutical industry's future, catalyzed by rapid economic growth, burgeoning h...

 May 14, 2024 | Report

CRISPR Therapies Extend Survival in ASFV-Infected Pigs, May Transform African Swine Disease Management

Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, an...

 May 07, 2024 | Report

Bioeconomic Powerhouse: APAC’s Strategic Blueprint for Dominating the Global Bioeconomy

The Asia-Pacific (APAC) region, characterized by its diverse cultures and economies, is increasingly recognized as a critical player in the global bioecono...

 April 16, 2024 | Report

Rising Prevalence of Inflammatory Bowel Disease in Developing Countries Signals Urgent Need for Innovative Treatments

IBD, or Inflammatory Bowel Disease, traditionally more prevalent in developed nations, is increasingly observed in developing regions like China....

 April 11, 2024 | News

Lunit Reveals Positive Study Results for Head and Neck Cancer Immunotherapy

Lunit, a global leader in AI-driven cancer diagnostics and therapy solutions, is thrilled to share the publication of a groundbreaking study in the prestig...

 March 27, 2024 | News

From Penicillin to Precision: The Ascendant Trajectory of Life Sciences Investments

The journey of the life sciences sector, from the serendipitous discovery of penicillin—an event that revolutionized the treatment of bacterial infec...

 March 26, 2024 | Report

Indian Pharmaceutical Sector Soars: Q4 2023 Growth Trends and Insights

    Indian Pharma Q4 Market Insights report Accelerating innovation for a healthier world View in web browse...

 March 18, 2024 | Report

Novel Molecules From Generative AI to Phase II: Pioneering TNIK Inhibitors for Fibrotic Diseases

  In a groundbreaking study published in Nature Biotechnology, Insilico Medicine, along with its collaborators, showcases the journey of INS018_055 f...

 March 13, 2024 | News

Eli Lilly Reveals Promising Phase 3 Results for Lebrikizumab in Patients with Skin of Color

Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color...

 March 11, 2024 | News

Visionary Titans: The Female Force Redefining the BioPharma Industry

In a domain where innovation meets executive excellence, these distinguished women infuse the biopharmaceutical industry with a blend of scientific creativ...

 March 08, 2024 | News

Bayer Secures Third Consecutive Legal Victory in Roundup™ Product Liability Cases

Bayer achieved a significant milestone with its third consecutive trial victory in the Kline Roundup™ product liability trial...

 March 06, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

 March 06, 2024 | News

Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC

In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...

 March 05, 2024 | Interaction


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close